TerminatedNCT01239173

Emotional Memory Reactivation in PTSD

Medication studyAges 18–50France

The study in practice

Understand this study

Listed age limits: 18 years to 50 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateSeptember 2010

Recruitment status: Terminated
Enrollment listed in the registry: 5
Sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: France
Age range: From 18 Years to 50 Years
Official registry ID: NCT01239173
Official title: Show the full official title
Reliving the Traumatic Event in Posttraumatic Stress Disorder: An Emotional Memory Reactivation Pathology? An fMRI Study

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Terminated

Paris

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Assistance Publique - Hôpitaux de Paris.

Does this study involve medication?

Yes. The study involves medication, including AVLOCARDYL and Placebo.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.